137 related articles for article (PubMed ID: 2228028)
1. Complement gene expression in hepatic and extrahepatic tissues of NZB and NZB x W (F1) mouse strains.
Passwell JH; Schreiner GF; Wetsel RA; Colten HR
Immunology; 1990 Oct; 71(2):290-4. PubMed ID: 2228028
[TBL] [Abstract][Full Text] [Related]
2. Local extrahepatic expression of complement genes C3, factor B, C2, and C4 is increased in murine lupus nephritis.
Passwell J; Schreiner GF; Nonaka M; Beuscher HU; Colten HR
J Clin Invest; 1988 Nov; 82(5):1676-84. PubMed ID: 3183062
[TBL] [Abstract][Full Text] [Related]
3. Differences in the occurrence of hypertension among (NZB X NZW)F1, MRL-lpr, and BXSB mice with lupus nephritis.
Rudofsky UH; Dilwith RL; Roths JB; Lawrence DA; Kelley VE; Magro AM
Am J Pathol; 1984 Jul; 116(1):107-14. PubMed ID: 6377906
[TBL] [Abstract][Full Text] [Related]
4. Mononuclear phagocyte system dysfunction in murine SLE: abnormal clearance kinetics precede clinical disease.
Meryhew NL; Shaver C; Messner RP; Runquist OA
J Lab Clin Med; 1991 Mar; 117(3):181-93. PubMed ID: 2002275
[TBL] [Abstract][Full Text] [Related]
5. Regulation of plasma complement C4 and factor b levels in murine systemic lupus erythematosus.
Garlepp MJ; Hart DA; Fritzler MJ
J Clin Lab Immunol; 1989 Mar; 28(3):137-41. PubMed ID: 2738911
[TBL] [Abstract][Full Text] [Related]
6. Cellular specificity of murine renal C3 expression in two models of inflammation.
Ault BH; Colten HR
Immunology; 1994 Apr; 81(4):655-60. PubMed ID: 8039815
[TBL] [Abstract][Full Text] [Related]
7. Genetic studies on the skin lupus band test in New Zealand mice.
Furukawa F; Maruyama N; Yoshida H; Hamashima Y; Hirose S; Shirai T
Clin Exp Immunol; 1985 Jan; 59(1):146-52. PubMed ID: 3871675
[TBL] [Abstract][Full Text] [Related]
8. Perforin mRNA expression in the inflamed tissues of NZB/W F1 lupus mice decreases with methylprednisolone treatment.
Nakamura T; Ebihara I; Tomino Y; Okumura K; Koide H
Am J Pathol; 1991 Oct; 139(4):731-6. PubMed ID: 1928297
[TBL] [Abstract][Full Text] [Related]
9. Identification of systemically expanded activated T cell clones in MRL/lpr and NZB/W F1 lupus model mice.
Zhou G; Fujio K; Sadakata A; Okamoto A; Yu R; Yamamoto K
Clin Exp Immunol; 2004 Jun; 136(3):448-55. PubMed ID: 15147346
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulatory effects of H.P. Acthar Gel on B cell development in the NZB/W F1 mouse model of systemic lupus erythematosus.
Decker DA; Grant C; Oh L; Becker PM; Young D; Jordan S
Lupus; 2014 Jul; 23(8):802-12. PubMed ID: 24759631
[TBL] [Abstract][Full Text] [Related]
11. Genomic view of IFN-alpha response in pre-autoimmune NZB/W and MRL/lpr mice.
Lu Q; Shen N; Li XM; Chen SL
Genes Immun; 2007 Oct; 8(7):590-603. PubMed ID: 17728792
[TBL] [Abstract][Full Text] [Related]
12. Renal platelet-derived growth factor gene expression in NZB/W F1 mice with lupus and ddY mice with IgA nephropathy.
Nakamura T; Ebihara I; Nagaoka I; Tomino Y; Koide H
Clin Immunol Immunopathol; 1992 May; 63(2):173-81. PubMed ID: 1611719
[TBL] [Abstract][Full Text] [Related]
13. New insights into disease-specific absence of complement factor H related protein C in mouse models of spontaneous autoimmune diseases.
Mehta G; Ferreira VP; Skerka C; Zipfel PF; Banda NK
Mol Immunol; 2014 Nov; 62(1):235-48. PubMed ID: 25033230
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the alternative complement pathway by antisense oligonucleotides targeting complement factor B improves lupus nephritis in mice.
Grossman TR; Hettrick LA; Johnson RB; Hung G; Peralta R; Watt A; Henry SP; Adamson P; Monia BP; McCaleb ML
Immunobiology; 2016 Jun; 221(6):701-8. PubMed ID: 26307001
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the genetic encoding of oestradiol suppression of delayed-type hypersensitivity in (NZB x NZW) F1 mice.
Carlsten H; Holmdahl R; Tarkowski A
Immunology; 1991 Jun; 73(2):186-90. PubMed ID: 2071164
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of lupus-like autoimmune disease in NZB/WF1 mice after treatment with a blocking monoclonal antibody specific for complement component C5.
Wang Y; Hu Q; Madri JA; Rollins SA; Chodera A; Matis LA
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8563-8. PubMed ID: 8710910
[TBL] [Abstract][Full Text] [Related]
17. Resistance to tolerance induction is not prerequisite to development of murine SLE.
Izui S; Masuda K
J Immunol; 1984 Dec; 133(6):3010-4. PubMed ID: 6491280
[TBL] [Abstract][Full Text] [Related]
18. Genetic studies of autoimmunity in New Zealand mice. IV. Contribution of NZB and NZW genes to the spontaneous occurrence of retroviral gp70 immune complexes in (NZB X NZW)F1 hybrid and the correlation to renal disease.
Maruyama N; Furukawa F; Nakai Y; Sasaki Y; Ohta K; Ozaki S; Hirose S; Shirai T
J Immunol; 1983 Feb; 130(2):740-6. PubMed ID: 6217253
[TBL] [Abstract][Full Text] [Related]
19. T cell cytokine imbalance towards production of IFN-gamma and IL-10 in NZB/W F1 lupus-prone mice is associated with autoantibody levels and nephritis.
Enghard P; Langnickel D; Riemekasten G
Scand J Rheumatol; 2006; 35(3):209-16. PubMed ID: 16766368
[TBL] [Abstract][Full Text] [Related]
20. Administration of fasudil, a ROCK inhibitor, attenuates disease in lupus-prone NZB/W F1 female mice.
Stirzaker RA; Biswas PS; Gupta S; Song L; Bhagat G; Pernis AB
Lupus; 2012 May; 21(6):656-61. PubMed ID: 22345122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
